LumiraDx Continues Commercial Expansion of its Rapid MicrofluidicImmunoassay HbA1c Test
London (ots/PRNewswire)
-
Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa
LumiraDx Limited
(Nasdaq: LMDX)
,
a next-generation point of care diagnostics company, today announced the continued commercial...
Zur Pressemeldung auf www.ots.at